Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMET: Etanercept plus methotrexate vs methotrexate alone in active early rheumatoid arthritis
2004-000563-96Phase 4Completed
- Sponsor
- Wyeth
- Start
- Sep 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Etanercept + methotrexate with Methotrexate monotherapy (2 arms). Primary endpoints: Radiographic progression and Clinical disease activity. Started Sep 2004; status: completed.
02
Drugs
etanerceptmethotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2004-000563-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000563-96.